Does TRIPTORELIN Cause Ovarian hyperstimulation syndrome? 356 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 356 reports of Ovarian hyperstimulation syndrome have been filed in association with TRIPTORELIN (TRIPTODUR). This represents 6.6% of all adverse event reports for TRIPTORELIN.
356
Reports of Ovarian hyperstimulation syndrome with TRIPTORELIN
6.6%
of all TRIPTORELIN reports
3
Deaths
307
Hospitalizations
How Dangerous Is Ovarian hyperstimulation syndrome From TRIPTORELIN?
Of the 356 reports, 3 (0.8%) resulted in death, 307 (86.2%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Ovarian hyperstimulation syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIPTORELIN. However, 356 reports have been filed with the FAERS database.
What Other Side Effects Does TRIPTORELIN Cause?
Off label use (545)
Death (362)
Needle issue (242)
Disease progression (203)
Product dose omission issue (178)
Drug ineffective (175)
Weight increased (167)
Hot flush (153)
Headache (145)
Injection site pain (138)
What Other Drugs Cause Ovarian hyperstimulation syndrome?
CHORIOGONADOTROPIN ALFA (1,016)
FOLLITROPIN (718)
GANIRELIX (672)
PROGESTERONE (293)
MENOTROPINS (238)
LUTROPIN ALFA (194)
GONADOTROPHIN, CHORIONIC (173)
FOLLITROPIN BETA (163)
FOLLITROPIN ALFA (138)
LETROZOLE (130)
Which TRIPTORELIN Alternatives Have Lower Ovarian hyperstimulation syndrome Risk?
TRIPTORELIN vs TRISODIUM
TRIPTORELIN vs TROFINETIDE
TRIPTORELIN vs TROFOSFAMIDE
TRIPTORELIN vs TROPATEPINE
TRIPTORELIN vs TROPICAMIDE